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What is known about the topic
•	 National	 guidelines,	 which	 include	 knowledge	
about	 cost-effective	 practice	 based	 on	 econom-
ic	 evidence,	 can	 importantly	 inform	 resource	
allocations.
•	 The	 National	 Institute	 for	 Health	 and	 Care	 Excel-
lence	(NICE)	is	the	first	health	technology	assessment	
agency	to	produce	social care	guidelines.
•	 It	 is	 important	 that	 commissioners,	 providers	 and	
users	 of	 social	 care	 understand	 how	 guidelines	
are	 developed,	 including	 the	 role	 of	 economic	
evidence.






•	 We	 propose	 the	 use	 of	 economic	 evidence	 in	 social	
care	 going	 forward,	 including	 recommendations	 for	
research.
Background
National social care guidelines in England
To	 support	 efficient	 resource	 allocation	 in	 health	 and	
social	 care,	 many	 countries	 have	 systems	 that	 promote	
evidence-based	practice	through	national	guidelines,	 led	
by	health	technology	assessment	(HTA)	or	Guideline	agen-
cies.	 National	 guidelines	 typically	 include	 systematically	
developed	statements	on	 intervention	effectiveness	 that	
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Value for Money in Social Care: The Role of Economic 
Evidence in the Guideline Development Process of 
the National Institute for Health and Care Excellence 
in England
Annette Bauer*, Michela Tinelli*, Helen Weatherly†, Beth Anderson†, Bernadette Li‡, 
Bhash Naidoo‡, Rachel Kettle‡ and Martin Knapp*
In England, the National Institute for Health and Care Excellence (NICE) has been responsible for devel-
oping social care guidelines since 2012. Internationally, it is the first health technology assessment and 
guideline agency that specifically includes social care. As is the case for NICE’s clinical and public health 
guidance, social care guidelines comprise recommendations based on the best available evidence of effec-
tiveness and cost-effectiveness. This paper provides an overview of how economic evidence is used within 
social care guideline development.
Firstly, the paper describes the guideline development and quality assurance process, in addition to the 
roles and responsibilities of the technical team and guideline committee members. Secondly, the paper 
summarises how economic evidence is reviewed, generated, and used to inform recommendations, with 
examples given to highlight some of the challenges and opportunities that can be encountered. The paper 
culminates with proposals for the use of economic evidence in social care in England going forward and 
makes recommendations for further research in this area.
The paper posits that guidelines are an important vehicle for supporting evidence-based practice in 
social care and that economic evidence is a critical kind of evidence to include. As economic evidence in 
social care becomes more widely available, it can be increasingly used to produce useful and accessible 
information for decision makers. Further research is needed to understand the impact of implementing 
economic evidence-based recommendations in social care practice.
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et	 al.,	 2004).	 The	 body	 responsible	 for	 developing	 evi-
dence-based	 guidelines	 on	 health,	 public	 health	 and	
social	care	in	England	is	the	National	Institute	for	Health	
and	Care	Excellence	(NICE).	Whilst	originally	mandated	to	
develop	 clinical	 guidelines,	NICE’s	 remit	was	 broadened	
in	2012	 to	encompass	 social	 care.	 It	 is	 the	 first	national	
HTA/Guideline	agency	 to	develop	social	 care	guidelines,	
therefore	offering	a	unique	learning	opportunity	for	other	
health	 and	 care	 systems.	 To	 date,	 NICE	 has	 developed	
approximately	20	adult	 social	 care	guidelines	 (Table 1),	
with	each	guideline	encompassing	between	50	and	100	
recommendations.	 Recommendations	 vary	 widely	 with	
regard	 to	 their	 scope,	 ranging,	 for	 example,	 from	 those	
that	 describe	 over-arching	 principles	 of	 care	 to	 those	
focused	on	specific	interventions.
Importance of economic evidence in NICE guidelines
Recommendations	made	 by	NICE	 need	 to	 be	 informed	
by	evidence	not	only	on	what	works	but	also	on	what	is	
considered	 ‘good	 value	 for	money’.	 The	 important	 role	
of	 economic	 evidence	 in	 NICE	 guidelines	 goes	 back	 to	
its	beginnings	in	1999,	when	NICE	was	created	with	the	
specific	purpose	to	ensure	a	more	equal	distribution	of	
healthcare	 and	 health	 outcomes	 under	 resource	 con-
straints.	 Since	 then,	 economic	 evaluations	 have	 played	
a	key	 role	 in	 informing	 recommendations	 (Dakin	et	 al.,	
2015),	 providing	 information	 about	 the	 added	 benefits	
from	an	intervention	relative	to	its	costs,	in	comparison	
with	 standard	 care,	 using	 value-for-money	 thresholds	
that	 allow	 consistent	 decision	 making	 across	 various	
areas	of	health	(Ciani	&	Jommi,	2014;	Taylor	et	al.,	2004).	
(These	 thresholds	 are	 used	 to	 inform	 decisions	 about	
recommendations.	 If,	 for	 example,	 an	 intervention	 that	
is	being	appraised	is	more	effective	than	standard	prac-
tice	but	also	more	expensive,	it	is	not	immediately	clear	
whether	 –	 on	 economic	 grounds	 –	 to	 recommend	 its	
widespread	use.	Having	a	threshold	provides	a	reference	
point	 to	 guide	 discussions	 about	 whether	 the	 higher	





appropriate	 pricing	 consistent	with	 scientific	 and	 social	






Importance of evidence-based practice in social care
Guideline-driven	 evidence-based	 practice	 is	 newer	 to	
social	care	than	to	the	clinical	field	(Gould,	2010;	Specht,	
2013).	 In	 part,	 this	 is	 because	 of	 challenges	 of	 generat-
ing	evidence	on	what	works	for	heterogeneous,	relatively	




needs	 arising	 from	 illness,	 disability,	 old	 age	 or	 poverty	
(Weatherly	et	al.,	2017).	Delivered	through	a	local	‘mixed	
economy’	 of	 statutory	 and	 non-statutory	 providers	 and	
funding	sources	 (Wistow	et	al.,	1994),	 content,	 coverage	
and	quality	of	social	care	can	vary	considerably	between	





tured	 ways	 that	 are	 experience-based	 rather	 than	
experiment-based	 (Gould	 &	 Kendall,	 2007).	 Therefore	
unsurprisingly,	 there	 are	 many	 fewer	 (economic)	 evalu-
ations	 in	 social	 care	 than	 in	 health	 care	 (Tinelli	 et	 al.,	
2020).	However,	the	role	of	national	social	care	guidelines	
in	 facilitating	evidence-based	practice	has	more	 recently	
received	 attention	 by	 some	 governments,	 such	 as	 in	
England	(Gould	&	Kendall,	2007;	Leng,	2019)	and	Canada	
(Beauchamp,	2015).	 In	contrast	 to	what	 is	known	about	





there	 is	 limited	 research	 describing	 and	 analysing	 the	
guideline	 development	 in	 social	 care.	 A	 recent	 national	
review	 in	 England	 found	 that	 few	 care	home	 staff	were	
aware	 of	 the	 NICE	 social	 care	 guidelines	 (Leng,	 2019),	
highlighting	 the	 need	 for	more	 information	 about	 how	
they	are	developed	and	why	they	are	valuable.
Method
Aims and approach taken in this paper
In	 this	paper,	we	describe	 the	NICE	approach	 to	devel-
opment	 of	 national	 social	 care	 guidelines,	 specifically	
how	 economic	 evidence	 is	 reviewed,	 analysed,	 synthe-
sised	 and	 presented	 to	 inform	 practice-focused	 recom-
mendations.	 In	doing	so,	we	seek	 to	 support	 the	social	
care	 sector’s	 understanding	 of,	 and	 capacity	 to	 engage	









the	 types	 of	 guidelines	 produced	 thus	 far.	 Next,	 in	 the	


































Publication date Title Guideline programme Titles of economic evidence 
reviews and economic analysis
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Publication date Title Guideline programme Titles of economic evidence 
reviews and economic analysis
Type of economic analysis (as outlined in the 
‘economic plan’)





Guidelines in development 






















Not yet known Advocacy	services	for	adults	with	health	and	
social	care	needs	(NICE,	2020b)
Social	care	 Not	yet	available Not	yet	available
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NICE social care guidelines: History, the manual and 
actors




Institute	 for	 Excellence,	 commissioned	 by	 NICE	 (Social	






for	 reviewing	 and	 synthesising	 economic	 evidence	 and	
conducting	 economic	 analysis.	 Since	 2018,	 the	National	
Guideline	Alliance	 (NGA),	 based	 at	 the	Royal	 College	 of	
Obstetricians	 and	 Gynaecologists,	 has	 developed	 NICE	
social	care	guidelines.
As	 mentioned,	 at	 least	 twenty	 guidelines	 relevant	 to	
adult	social	care	were	developed	or	are	currently	in	devel-
opment.	Exact	numbers	are	difficult	to	determine	as	some	
of	 the	 social	 care-relevant	 guidelines	 were	 developed	
under	 clinical	 and	 public	 health	 programmes,	 such	 as	
those	for	dementia	or	autism.
Manual and stages of guideline development
The	process	of	developing	guidelines,	 including	the	role	
of	 reviewing	 economic	 evidence,	 is	 set	 out	 in	 the	 NICE	
methods	manual	 (NICE,	2020c).	A	 variety	of	 evidence	 is	
considered,	consisting	of	qualitative	studies,	quantitative	
studies	 including	 cost-effectiveness	 evidence	 and	 expert	





weeks,	on	average	–	 form	 the	backbone	of	 this	process.	
These	meetings	–	which	are	chaired	by	a	subject	matter	
expert	 and	 held	 in	 accordance	 with	 NICE	 processes	 –	
involve	 the	 committee	 assessing	 the	 evidence	 emerging	
from	 the	 reviews	 and	 agreeing	 its	 reliability	 and	useful-
ness	for	informing	recommendations.

















The	 process	 of	 developing	 a	 social	 care	 guideline	 can	
be	 lengthy	 (up	 to	 24	months,	 depending	 on	 its	 scope)	
and	 involves	 multiple	 organisations	 and	 individuals	
from	diverse	backgrounds	working	in	close	collaboration	
(Figure 1).	Whilst	there	are	many	activities	involved,	from	






oper	 organisation,	 reviews	 evidence	 and	 presents	 it	
to	 the	 guideline	 committee	 in	 accessible	 format.	 The	
team	 includes	 information	 specialist(s),	 reviewer(s)	 and	
economist(s)	who	 collaborate	with	NICE	and	 the	guide-
line	committee,	and	are	 responsible	 for:	 supporting	 the	
committee,	 and	 documenting	 their	 recommendations,	
discussions	 and	 decisions;	 conducting	 evidence	 reviews	
and	 syntheses;	 and	 ensuring	 appropriate	 methods	 are	
used.	 The	 guideline	 committee	 is	 an	 independent	 advi-
sory	 group	 that	 ultimately	 co-authors	 the	 guideline	
(NICE,	 2020c).	 Committee	 members	 are	 appointed	 fol-
lowing	a	voluntary	application	process	and	include	prac-
Figure 1:	 Overview	 of	 the	NICE	 guideline	 development	
process	and	focus	of	the	paper	on	the	development	stage.
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titioners,	 commissioners,	 service	 providers,	 people	with	
lived	experience	and	carers,	 and	 researchers.	 They	meet	
regularly	(every	1.5	months)	over	the	course	of	the	guide-
line	development	process	 (c.18	months).	At	 those	meet-
ings,	 the	 committee	 prioritises	 and	 interprets	 evidence	
presented	 to	 them	by	 the	 technical	 team,	 and	develops	
recommendations	 for	 practice,	 taking	 account	 of	 stake-
holder	 views.	 Registered	 stakeholders,	 that	 is,	 organisa-
tions	that	want	to	be	involved	in	the	process,	can	apply	
to	 attend	 a	workshop	 that	 informs	 development	 of	 the	






Economic evidence reviews for NICE social care 
guidelines
Table 1	 presents	 an	 overview	 of	 NICE	 adult	 social	 care	
guidelines	and	the	economic	evidence	reviews	and	anal-
yses	 that	were	conducted	as	part	of	 those.	This	 includes	




An	 important	 part	 of	 the	 development	 process	 is	 the	
review	of	evidence,	which	includes	review	of	economic	evi-
dence.	 There	 are	 a	 number	 of	 steps.	 The	 scoping	 of	 the	
guideline	 involves	 deciding	 the	 extent	 of	 the	 area	 and	
subject	matter	to	be	addressed:	this	includes	formulating	
review	 questions,	 including	 questions	 of	 cost-effective-
ness,	and	identifying	priorities	for	any	original	economic	
analyses	 as	 part	 of	 guideline	 development.	Searching	 of	




on	 predefined	 inclusion	 and	 exclusion	 criteria.	 Critical 
appraisal	includes	assessment	of	relevance	and	quality	of	
included	 (economic)	 studies.	Evidence synthesis	 refers	 to	
summarising	 findings	 into	 evidence	 statements.	 Finally,	
the	analysis step	includes	interpretation	of	evidence	and	
formulation	of	recommendations.	The	guideline	develop-




use	 two	main	 sources	 of	 cost-effectiveness	 evidence:	 1)	
economic	 evaluation	 studies	 that	 are	 published,	 identi-







line,	 areas	 to	 be	 covered,	 and	 draft	 review	 questions.	
Areas	covered	by	the	guideline,	and	which	are	subject	to	




(3–4	 questions),	 depending	 on	 the	 topic	 in	 question	
and	the	overall	timeframe	for	delivery.	Review	questions	
in	 social	 care	 relate	 to	 effectiveness,	 cost-effectiveness,	










thesising	 published	 evidence.	 Working	 with	 the	 guide-
line	 committee,	 the	 technical	 team	 can	make	 decisions	
about	which	types	of	evidence	to	prioritise	for	inclusion,	









ies	 in	which	 the	 control	 group	 (i.e.,	 the	group	 receiving	






for	 clinical	 topics	 (and	many	 public	 health	 topics)	 cost-
utility	 analysis	 is	most	 common.	 In	 cost-utility	 analysis,	
the	difference	in	total	costs	between	the	two	study	groups	
is	compared	with	the	between-group	difference	in	health-
related	 quality	 of	 life	 (expressed	 in	 quality-adjusted	 life	
years).	 For	 social care	 topics,	 other	 types	 of	 economic	
evaluations	are	more	common	and	are	considered	in	the	
review	process.	 This	 includes	 cost-savings,	 cost-effective-
ness	 and	 cost-consequences	 studies	 (explained	 below).	











potential	 cost	 savings	 or	 no	 difference	 in	 costs,	 some	


















in	 which	 additional	 economic	 analyses	 will	 be	 carried	





tive	 guideline.	 NICE	 requests	 that	 additional	 economic	
analyses	should	be	carried	out	for	areas	of	interventions	
or	service	delivery	likely	to	have	greatest	impact	on	costs	
and	benefits.	 In	 social	 care,	 the	 final	 choice	of	 areas	 for	
economic	 analyses	 is	 strongly	 influenced	 by	 availability	
of	 data	 to	 carry	 out	 additional	 analyses.	 NICE	 provides	
guidance	on	prioritising	economic	areas	in	its	manual.	A	




Types of analyses. The	economic	analysis	 typically	uses	




























Time horizon. The	 time	 horizon	 refers	 to	 the	 number	
of	months	or	years	covered	by	a	model.	Whether	a	short-	
or	long-term	model	is	more	appropriate	depends	on	the	
expected	 impact	 on	 costs	 and	 outcomes.	 The	 aim	 of	 a	
model	is	to	capture	all	costs	and	outcomes	relevant	to	the	
decision. Modelling	utilises	data	 from	various	published	
sources.	 Typically,	 a	 wider	 range	 of	 relevant	 costs	 and	
outcomes	can	be	included	in	the	analysis	than	would	be	
feasible	 through	primary	 data	 collection	 carried	 out	 for	




care,	 which	 might	 be	 influenced	 by	 interventions	 that	
seek	to	restore	or	maintain	a	person’s	independence	(e.g.,	
reablement).




and	 recommendations.	 The	 focus	of	NICE	 is	on	 costs	 to	
the	health	and	social	care	sectors,	but	other	costs	might	
be	included	as	part	of	sensitivity	(scenario)	analysis	if	rel-
evant.	 In	 social	 care,	 the	 contribution	 of	 unpaid	 care	 is	
often	important.	Carer	time	and	skills	represent	resources	
to	 which	 costs	 can	 be	 attached.	 Hours	 of	 unpaid	 care	
typically	make	 up	 a	 high	 proportion	 of	 the	 overall	 care	
provided	 for	 someone	 using	 social	 care	 (Brimblecombe	
et	al.,	2018).	However,	until	recently	few	evaluations	have	





benefit	 side),	 which	 complicates	 comparisons	 of	 these	
costs	across	evaluations.
Methods for considering outcomes. Whilst	for	clinical	and	
public	health	guidelines,	only	or	primarily	health	effects	
can	be	considered,	in	social	care	there	is	no	such	restric-
tion	 and	 all	 benefits	 as	 they	 are	 experienced	 by	 people	
using	 services	 or	 their	 carers	 can	 be	 included.	 In	 social	
care	guidelines,	 the	consideration	of	user	and	carer	out-
comes	and	experiences	is	particularly	important	(Bauer	et	
al.,	 2020)	 and	 can	 influence	 the	need	 for	 adapting	pro-
cesses	of	guideline	development	such	as	how	evidence	is	
reviewed,	and	selection	of	guideline	committee	members	
(NICE,	 2018e).	 The	 decision	 about	 which	 outcomes	 are	
included	in	the	analysis	determines	the	type	of	economic	
evaluation.	If	outcomes	are	expressed	in	the	form	of	qual-






case’	 (=main)	 analysis	 (NICE,	2020c).	Additional	 analysis	
can	 include	cost-effectiveness analysis,	 in	which	costs	are	
compared	 against	 outcomes	presented	 in	 ‘natural	 units’	
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(e.g.,	 independence	 in	 activities	 of	 daily	 living),	 cost-
consequences analysis,	which	evaluates	 several	outcomes	
alongside	 the	 costs,	 cost-benefit analysis,	which	 converts	
outcomes	 into	 monetary	 values,	 or	 cost-minimisation 
analysis,	which	only	considers	costs	expended	versus	costs	
saved	(Drummond	et	al.,	2015).
Different	 from	 clinical	 and	 public	 health	 guidelines,	
NICE	allows	the	inclusion	of	capability	or	social	care-related	






compared	 to	 their	 counterparts	 in	 the	 health	 field,	 and	
therefore	 for	many	 topic	areas	no	economic	evaluations	
exist	which	 use	 those	 outcome	measures,	which	means	
that	there	is	a	limited	evidence	base	on	which	NICE’s	eco-
nomic	 analysis	 could	 draw	 (although	 this	 is	 changing).	
There	is	currently	no	recognised	threshold	against	which	
to	 compare	 cost-per-outcome-unit	 estimates	 that	would	





control	group.	This	 is	often	called	 the	effect	 size,	 and	 it	
strongly	 depends	 on	 population	 characteristics,	 service	
infrastructure,	and	other	contextual	factors.	For	example,	









an	evaluation	carried	out	 in	a	 setting	 that	 is	 sufficiently	
similar	to	the	one	relevant	to	the	national	context.










Costs of Health and Social Care	(Curtis	&	Burns,	2019)	and	
NHS	Reference	Costs	(NHS	Digital,	2020);	national	audits	




Sensitivity analysis. In	 economic	 evaluations,	 and	 in	
particular	 in	 decision-analytic	modelling,	 there	 are	 vari-
ous	 sources	 of	 uncertainty,	 and	 so	 additional	 sensitiv-
ity	 analysis	 is	 carried	 out	 to	 investigate	 the	 impact	 of	
these	uncertainties	 in	model	 inputs	on	 the	 final	 results.	
Different	approaches	are	possible,	including	deterministic	
sensitivity	 analyses	 (e.g.,	 scenario,	 threshold,	 one-way	or	
multi-way	sensitivity	analysis)	and	probabilistic	sensitivity	
analysis	(Drummond	et	al.,	2015).
Discounting and inflation. Costs	 and	 outcomes	 need	
to	be	discounted	(e.g.,	at	3.5%)	when	the	analysis	covers	










Economic evidence synthesis and interpretation
Economic evidence statements
Economic	 evidence	 statements	 are	 summaries	 of	 eco-
nomic	evidence	reviewed	and	of	any	additional	economic	
analysis	carried	out.	They	present	the	detail	of	the	study	
findings,	 together	 with	 interpretations	 based	 on	 study	














tion	 (compared	with	 those	who	did	not)	 divided	by	 the	








opportunity	 cost	 (i.e.,	 the	 QALYs	 that	 could	 have	 been	




NICE	 does	 not	 have	 a	 threshold	 for	 any	 other	 outcome	
measure.




as	 to	 whether	 the	 decision-maker	 thinks	 that	 the	 addi-
tional	outcome	associated	with	the	intervention	is	worth	
the	additional	cost	(measured	on	a	standardised	scale).
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An	important	limitation	of	using	cost-per-QALY	thresh-
olds	when	deciding	whether	an	intervention	is	cost-effec-




































































example,	 the	guideline	 ‘Intermediate	care	 including	rea-
blement’	includes	an	economic	consideration	explaining	
how	recommendations	on	offering	home-based	interme-
diate	 care	might	apply	differently	 for	different	 localities	
depending	on	their	health	care	infrastructure,	and	that	–	
especially	in	rural	areas	–	it	might	not	be	cost-effective	to	
offer	 home-based	 intermediate	 care	 as	 an	 alternative	 to	
bed-based	intermediate	care	(NICE,	2017	p.192).
Recommendations in guidelines
The	 recommendations	are	 the	most	 important	outcome	
of	 the	 guideline	 development.	 During	 the	 review pro-
cess,	the	technical	team	presents	the	(economic)	evidence	
statements	for	each	review	question	to	the	guideline	com-
mittee.	 The	 committee	 draws	 recommendations,	 which	
are	updated	iteratively	as	additional	evidence	is	identified.	
Recommendations	 are	 derived	 directly	 from	 evidence	
statements,	and	NICE	provides	explanations	as	 to	which	
evidence	 statement(s)	 supported	 the	 recommendations.	
The	‘Evidence	to	recommendations’	section	of	the	guide-
line	(since	2018,	this	is	‘Committee	discussion	of	the	evi-





Recommendations	have	 different	 ‘strengths’	 reflecting	




Evidence	 statements	 can	 be	 strengthened	 or	 supple-
mented	 by	 committee	 consensus	 agreement.	 In	 some	
circumstances,	 the	 committee	 can	 also	 make	 recom-
mendations	 in	 the	absence	of	evidence	 if	 it	 can	achieve	
consensus	and	provide	a	clear	rationale	for	the	expected	
benefit	 for	 the	population	of	 interest.	 This	 occurs	more	
often	 in	 social	 care	 than	 in	 most	 areas	 of	 healthcare.	
Recommendations	 expected	 to	 have	 resource	 implica-
tions	need	to	be	supported	by	legislation	(e.g.,	Health	and	
Social	Care	Act	2014;	Equality	Act	2010;	Mental	Capacity	
Act	 2005)	 or	 by	 existing	 recognised	 national	 guide-
lines.	 Social	 care	guidelines	 can	also	 refer	directly	 to,	or	
include	 specific	 recommendations	 from,	 existing	 guide-
lines	accredited	by	NICE.	For	those	not	yet	accredited,	an	
Table 2:	Examples	of	recommendations	in	NICE	adult	social	care	guidelines	informed	by	economic	evidence.
Recommendations informed by 
economic evidence
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assessment	 needs	 to	 be	 conducted	 using	 relevant	 tools	
such	as	AGREEII	(Brouwers	et	al.,	2010).	This	approach	was	
used	to	consider	guidance	on	tools	and	ways	of	working	










We	sought	 to	provide	a	 comprehensive	overview	of	 the	
process	 by	 which	 economic	 evidence	 informs	 national	
social	care	guidelines	in	England.	Social	care	guidance	by	
NICE	plays	 an	 important	 role	 in	driving	evidence-based	
cost-effective	 social	 care	 practice	 (NICE,	 2019b).	 It	 also	
provides	 a	 potential	 vehicle	 for	 developing	 innovative	
social	care	economic	evaluation	methods,	although	NICE	





the	 National	 Institute	 for	 Health	 Research	 (NIHR),	 UK	
Research	 and	 Innovation	 and	 other	 research-funding	
bodies.	This	is	part	of	a	virtuous	circle	between	research,	







still	 scarce	 in	comparison	to	economic	evidence	 in	clini-
cal	and	public	health	fields	due	to	challenges	in	collecting	




















services	 and	 carers	 can	 better	 understand	 the	 type	 and	
quality	of	care	they	might	expect	to	receive.	Furthermore,	
there	 is	 opportunity	 for	 ongoing	 sector	 improvement	 if	
diverse	groups	of	 stakeholders	are	 involved	 in	guideline	
development	and	dissemination	in	future.
When	HTAs	of	drugs	or	clinical	 interventions	consider	
cost-effectiveness	 in	 their	 review	process,	 it	 is	often	one	
of	the	most	important	criteria	in	determining	whether	a	
new	 drug	 is	 recommended	 (Cerri,	 Knapp,	 &	 Fernández,	
2014;	Dakin	et	al.,	2015).	It	would	be	useful	to	understand	
the	 influence	 of	 economic	 evidence	 on	 recommenda-
tions	 (also	 in	 relation	 to	other	 criteria	 such	as	effective-
ness,	 acceptability,	 equity	 and	 needs)	 across	 social care	
guidelines.	 It	 would	 also	 be	 useful	 to	 understand	 how	
recommendations	 informed	by	 economic	 evidence	have	
been	 implemented	 in	 practice,	 and	 whether	 they	 led	
to	 the	 expected	 costs	 and	 benefits.	 Another	 need	 is	 to	
understand	which	 guidance	 areas	 cannot	be	 covered	by	
economic	 evidence,	 how	 those	 are	 reflected	 in	 research	
recommendations,	and	compare	those	across	guidelines.
Table 3:	Types	of	recommendations	in	NICE	guidelines.
Strength of recommendation 
& wording
Strengths of evidence 
required
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